Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Brixton Biosciences Inc. maintains 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units, reflecting a diversified prosecution landscape despite the small volume of active cases. This distribution means that the company must navigate the preferences and requirements of 2 different points of contact at the patent office simultaneously. The presence of 2 distinct art units suggests that the technology being patented may span different sub-specialties within the broader engineering field. Practitioners must coordinate strategies across 2 different art units to address the current requirements of the portfolio.
AVIGAN, ADAM JOSEPH is the busiest examiner for the company, with 1 pending office action under review. This means the 2 pending actions are split evenly among the 2 examiners involved, as the busiest examiner pending count is only 1. Since no single examiner holds a majority of the pending cases, the legal team should be prepared for potentially different examiner behaviors and timelines. Monitoring the 2 distinct examiners will be necessary to maintain a cohesive prosecution strategy for the company's medical device innovations. The fact that no examiner manages more than 1 pending office action indicates a balanced workload across the current active docket.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AVIGAN, ADAM JOSEPH | 1 | 43.7% | +16.3% |
| VIGIL, TORIANA NICHOLE | 1 | 53.1% | +24.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17582262 | APPARATUS FOR CREATION OF INJECTABLE SLURRY | AVIGAN, ADAM JOSEPH | 44d overdue |
| 17629206 | METHODS OF CREATING A SUBSTANCE WITH DIFFERENT FREEZING POINTS BY ENCAPSULATION | VIGIL, TORIANA NICHOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17582262 | APPARATUS FOR CREATION OF INJECTABLE SLURRY | AVIGAN, ADAM JOSEPH | 44d overdue |
| 17629206 | METHODS OF CREATING A SUBSTANCE WITH DIFFERENT FREEZING POINTS BY ENCAPSULATION | VIGIL, TORIANA NICHOLE | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17582262 | APPARATUS FOR CREATION OF INJECTABLE SLURRY | AVIGAN, ADAM JOSEPH | 3794 | §103§112 | Final Rejection | 44d overdue | Pending | Jan 24, 2022 |
| 17629206 | METHODS OF CREATING A SUBSTANCE WITH DIFFERENT FREEZING POINTS BY ENCAPSULATION | VIGIL, TORIANA NICHOLE | 1612 | §103§112 | Non-Final OA | — | Pending | Jan 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial